enVVeno (NVNO) - Net Sales Margin

enVVeno Medical Corporation (NVNO) - corporate logo

The non-cyclical nature of producing innovative vein products provides enVVeno Medical (NVNO) with high macro-resilience. Business development relies on the commercialization of its valve for treating venous insufficiency and regulatory approval. The net commercial margin illustrates this potential, and the parameter has stabilized at 0.00. The stable operation of precision equipment and clean rooms prepares the company for capacity expansion.

enVVeno Corp (NVNO) - Return on Sales by Net Profit from 07/04/2022 to 11/20/2026

Financial and market metric breakdowns for enVVeno Medical (NVNO)

- share price and expert price forecast:
Summary company analytics:enVVeno Corp - NVNO
Manufactured product of enVVeno Corp

Institutional capital evaluates enVVeno Medical (NVNO) through the lens of its ability to generate sustainable free cash flow. The net profit margin reflects the portion of revenue converted into net income after deducting all operating expenses. Analyzing this trend captures the efficiency of cost management. Currently, this metric is limited by the lack of commercial sales of bioprostheses pending FDA approval. The stability of this metric will guarantee the asset's reliability once the ecosystem is launched.

Analysis of competing companies

BSX: Net Sales Margin|Return on Sales by Net Profit Edwards Lifesciences Corporation|RMD (ResMed Corporation) - Net Sales Margin|OmniPod (PODD) - Company Sales Margin|Net Sales Margin ZBH|Net Sales Margin coopercos.com (COO)|Net Sales Margin ALGN (aligntech.com)|Net Sales Margin Globus Medical Inc GMED|TMDX - Net Margin|ATEC: Net Margin|AORT (Artivion, Inc.) - Return on Sales by Net Profit|Enovis Corporation - Net Profit Rate|IART (Integra LifeSciences Inc.) - Net Sales Margin|Net Margin Establishment Labs Corp ESTA|Net Margin Beta Bionics, Inc. (BBNX)|IRADIMED CORPORATION (IRMD) - Net Profitability Margin|Embecta Health - Return on Sales by Net Profit|Net Sales Margin Tandem Diabetes Care TNDM|AxoGen Inc - Net Sales Margin|Company Sales Margin SI-BONE Inc SIBN|Orthofix (OFIX) - Net Margin|Return on Sales by Net Profit Bioventus Corp|Net Margin orthopediatrics.com|Return on Sales by Net Profit Treace Medical Concepts (TMCI)|Net Sales Margin SRTA|CARL - Net Margin|Net Margin RxSight, Inc. RXST|CLPT: Net Return on Sales|STXS: Return on Sales by Net Profit|neurostar.com - Company Net Profitability|Sight Sciences Inc. (SGHT) - Net Margin|Net Margin orchestrabiomed.com (OBIO)|Net Margin Anika Therapeutics, Inc.|Net Return on Sales NSPR (InspireMD Inc.)|Net Margin Jin Medical International Ltd (ZJYL)|Net Margin VANI (Vivani Medical)|Net Margin xtantmedical.com XTNT|Net Profit Rate NMTC|MODD - Net Margin|Net Profit Rate MYO (Myomo, Inc)|COCH (Envoy Medical, Inc.) - Return on Sales by Net Profit|Vivos Therapeutics, Inc. - Net Profit Rate|Return on Sales by Net Profit SINT|Return on Sales by Net Profit Tenon Medical (TNON)|Net Margin ReWalk Robotics Ltd (LFWD)|Company Sales Margin Autonomix|Net Sales Margin IVF (invobioscience.com)|bonebiologics.com - Net Margin|AXNX - Net Margin|BIOL (BIOLASE) - Net Return on Sales|Dynatronics Corporation (DYNT) - Net Margin|Net Return on Sales FNA|INVO (INVO Bioscience Inc.) - Net Sales Margin